Many breast cancer patients abandon endocrine treatment too soon, say researchers who suggest doctors use each consult to reinforce compliance messages. Clinical trials have shown that endocrine therapy halves the risk of recurrence and reduces cancer-related mortality in women with hormone-dependent primary breast cancer when taken for five years or longer, but research has shown ...
Breast cancer patients quitting endocrine therapy too soon
By Tessa Hoffman
2 Aug 2017